CCO Oncology Podcast
En podkast av Clinical Care Options

Kategorier:
189 Episoder
-
Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions
Publisert: 31.1.2022 -
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease
Publisert: 26.1.2022 -
Experts Answer Questions on Current and Emerging Options for Hemophilia A Management
Publisert: 14.1.2022 -
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
Publisert: 10.1.2022 -
Strategies for Secondary AML and Emerging Therapies for AML
Publisert: 10.1.2022 -
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Publisert: 10.1.2022 -
An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy
Publisert: 10.1.2022 -
Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications
Publisert: 22.12.2021 -
Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications
Publisert: 22.12.2021 -
Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
Publisert: 17.12.2021 -
The Evolving Role of TKIs in First-line Treatment of Advanced HCC
Publisert: 14.12.2021 -
Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers
Publisert: 23.11.2021 -
Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer
Publisert: 23.11.2021 -
Overcoming Acquired Resistance With Second-Generation TRK Inhibitors
Publisert: 9.11.2021 -
Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma
Publisert: 2.11.2021 -
PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape
Publisert: 26.10.2021 -
Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
Publisert: 21.10.2021 -
First-Generation TRK Inhibitors: Clinical Evidence and Indications
Publisert: 15.10.2021 -
PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm
Publisert: 14.10.2021 -
Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A
Publisert: 8.10.2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.